Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Schedule of Antidilutive Securities) (Details)

v3.19.3
Net Loss Per Share (Schedule of Antidilutive Securities) (Details) - shares
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 3,163,354 465,406
Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 838,429 61,144
Common stock warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 9,030,730 4,430,730